<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for OREX</title>
    <link />
    <description>Headlines for Orexigen Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Arena - Good Sales, Bad Sales, Long And Short</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1458991-arena-good-sales-bad-sales-long-and-short.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 24 May 2013 02:53:48 GMT</pubDate>
    </item>
    <item>
      <title>Commit To Purchase Orexigen Therapeutics At $3, Earn 23.3%</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11932700/1/commit-to-purchase-orexigen-therapeutics-at-3-earn-233.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 14:18:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Under $10 Set to Soar</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-under-10-set-soar.html-28.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 13:30:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Pipeline Obesity Treatments You Should Watch</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/3-pipeline-obesity-treatments-to-watch/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 22 May 2013 20:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Orexigen Therapeutics' CEO Presents at 2013 UBS Global Healthcare Services Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1454821-orexigen-therapeutics-ceo-presents-at-2013-ubs-global-healthcare-services-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 16:29:07 GMT</pubDate>
    </item>
    <item>
      <title>The 9 Most Obese Countries in the World</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/the-9-most-obese-countries-in-the-world/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 14:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Orexigen Therapeutics' Management Presents at Bank of America Merrill Lynch Health Care Conference -</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1438781-orexigen-therapeutics-management-presents-at-bank-of-america-merrill-lynch-health-care-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 22:33:03 GMT</pubDate>
    </item>
    <item>
      <title>Weight Loss Isn't Just for Looking Good Anymore</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/weight-loss-isnt-just-for-looking-good-anymore/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 19:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Vivus Starting To Gain The Advantage Over Arena</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1432481-vivus-starting-to-gain-the-advantage-over-arena.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 05:42:05 GMT</pubDate>
    </item>
    <item>
      <title>ARNA Sheds Light on Belviq Launch - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99072/arna-sheds-light-on-belviq-launch.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 09 May 2013 15:50:01 GMT</pubDate>
    </item>
    <item>
      <title>VIVUS Reports Wider Loss - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98993/vivus-reports-wider-loss.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 09 May 2013 08:16:01 GMT</pubDate>
    </item>
    <item>
      <title>Orexigen Therapeutics' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1416731-orexigen-therapeutics-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 20:34:03 GMT</pubDate>
    </item>
    <item>
      <title>Is Orexigen Therapeutics Burning Too Much Cash?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/is-orexigen-therapeutics-burning-too-much-cash/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Are Obesity Drugs a Lost Cause in Europe?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/05/are-obesity-drugs-a-lost-cause-in-europe/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 05 May 2013 15:00:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S.-Approved Obesity Drug Derailed in EU</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/04/arena-pharmaceuticals-earnings-may-2nd/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 04 May 2013 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Arena Withdraws Application for Weight-Loss Drug Approval in Europe</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/05/03/arena-withdraws-application-for-weight-loss-drug-approval-in-europe/.aspx?source=itxwebtxt0000015</link>
      <author>247wallst</author>
      <pubDate>Fri, 03 May 2013 08:30:18 GMT</pubDate>
    </item>
    <item>
      <title>Vivus And Anti-Obesity Sector Benefit From New Insurance Deal</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1388831-vivus-and-anti-obesity-sector-benefit-from-new-insurance-deal.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 09:11:38 GMT</pubDate>
    </item>
    <item>
      <title>Arena Faces A Convergence Of DEA And European Decisions</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1365041-arena-faces-a-convergence-of-dea-and-european-decisions.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 24 Apr 2013 05:47:23 GMT</pubDate>
    </item>
    <item>
      <title>Vivus Seeing Traction With Qsymia</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1354251-vivus-seeing-traction-with-qsymia.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 19 Apr 2013 10:45:29 GMT</pubDate>
    </item>
    <item>
      <title>Expanded Access for VIVUS' Qsymia - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97416/expanded-access-for-vivus-qsymia.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 18 Apr 2013 19:00:01 GMT</pubDate>
    </item>
  </channel>
</rss>
